- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04580199
Surgical Versus Non Surgical Management of Thyroid Nodule
October 7, 2020 updated by: Mahmoud Fahd
Surgical (Total or Hemithyroidectomy)Versus Non Surgical (Ethanol Ablation ,RF Ablation ,Laser Ablation) Management of Thyroid Nodule
To compare between surgical (hemi thyroidectomy and total thyroidectomy) and non-surgical (medical, ethanol injection,thermal ablation and laser photo coagulation) management of simple thyroid nodule regarding:
- Outcome of every type of management
- Feasibility of minimally invasive technique in management of simple thyroid nodule in Asyut university
- Complication of every type of management
Study Overview
Detailed Description
Thyroid nodules are very common in clinical practice; they are discovered by palpation in 3-7% and by ultrasound (US) in about 50% of the general population.
The majority of thyroid nodules are benign and asymptomatic.
The main management of benign thyroid nodules is observation and follow-up; however, a minority of them (10-15%) increase in size over time and may induce symptoms or cosmetic issues.
Surgical excision has been established as a treatment for symptomatic benign thyroid nodules.
thyroidectomy for benign thyroid disease continues to remain controversial, as there are many conflicting data published in the literature regarding the risk of hypothyroidism and recurrent laryngeal nerve injury stratified to indications for surgery, extent of thyroid resection and surgical volume .It carries a 2-10% risk of complications and neck scarring .Thyroid surgery is also costly and may not be appropriate for patients who have a high risk of surgical morbidity.Therefore, image-guided nonsurgical procedures such as ethanol ablation (EA) and thermal ablation have been proposed as alternative and less invasive approaches for the management of benign symptomatic thyroid nodules .These so-called thermoablative methods induce local thermodestruction, leading to nodule shrinkage and improvement of local symptoms.
Monopolar radiofrequency ablation (RFA) and EA is widely used as a nonsurgical treatment usually for cystic (i.e., pure cyst) or predominantly cystic benign thyroid nodules (i.e., cystic portion > 50%).
There is another method called US-guided percutaneous laser ablation (PLA) is a safe and effective therapeutic option as an alternative to surgery for benign symptomatic nodules
Study Type
Interventional
Enrollment (Anticipated)
100
Phase
- Not Applicable
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- complicated thyroid nodule
Exclusion Criteria:
- less than 18 malignant thyroid nodule
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Active Comparator: total thyroidectomy
excision of thyroid gland
|
to excise the thyroid gland
Other Names:
|
Active Comparator: hemi thyroidectomy
excision half of thyroid gland
|
to excise the thyroid gland
Other Names:
|
Active Comparator: ethanol ingection
ingection of ethanol into thyroid nodule under guidance of ultrasound
|
to excise the thyroid gland
Other Names:
|
Active Comparator: monopolar radiofrequency
using radiofrequency for ablation of thyroid nodule
|
to excise the thyroid gland
Other Names:
|
Active Comparator: laser photocaugulation
using laser for ablation of thyroid nodule
|
to excise the thyroid gland
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
shrinkage of the thyroid nodule
Time Frame: 2 years
|
decrease in the size of thyroid nodule
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Benjamin J, Hephzibah J, Cherian AJ, Mathew D, Shanthly N, Oommen R. Is hemi-thyroidectomy adequate in low risk differentiated thyroid cancer? World J Nucl Med. 2019 Apr-Jun;18(2):171-175. doi: 10.4103/wjnm.WJNM_70_18.
- Mauri G, Nicosia L, Della Vigna P, Varano GM, Maiettini D, Bonomo G, Giuliano G, Orsi F, Solbiati L, De Fiori E, Papini E, Pacella CM, Sconfienza LM. Percutaneous laser ablation for benign and malignant thyroid diseases. Ultrasonography. 2019 Jan;38(1):25-36. doi: 10.14366/usg.18034. Epub 2018 Sep 17.
- Hahn SY, Shin JH, Na DG, Ha EJ, Ahn HS, Lim HK, Lee JH, Park JS, Kim JH, Sung JY, Lee JH, Baek JH, Yoon JH, Sim JS, Lee KH, Baek SM, Jung SL, Kim YK, Choi YJ; Korean Society of Thyroid Radiology (KSThR); Korean Society of Radiology. Ethanol Ablation of the Thyroid Nodules: 2018 Consensus Statement by the Korean Society of Thyroid Radiology. Korean J Radiol. 2019 Apr;20(4):609-620. doi: 10.3348/kjr.2018.0696.
- Dobnig H, Amrein K. Monopolar Radiofrequency Ablation of Thyroid Nodules: A Prospective Austrian Single-Center Study. Thyroid. 2018 Apr;28(4):472-480. doi: 10.1089/thy.2017.0547. Epub 2018 Mar 20.
- Rahal Junior A, Falsarella PM, Mendes GF, Hidal JT, Andreoni DM, Lucio JFF, Queiroz MRG, Garcia RG. Percutaneous laser ablation of benign thyroid nodules: a one year follow-up study. Einstein (Sao Paulo). 2018 Nov 29;16(4):eAO4279. doi: 10.31744/einstein_journal/2018AO4279.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Anticipated)
December 1, 2020
Primary Completion (Anticipated)
December 1, 2021
Study Completion (Anticipated)
December 1, 2022
Study Registration Dates
First Submitted
October 2, 2020
First Submitted That Met QC Criteria
October 2, 2020
First Posted (Actual)
October 8, 2020
Study Record Updates
Last Update Posted (Actual)
October 9, 2020
Last Update Submitted That Met QC Criteria
October 7, 2020
Last Verified
October 1, 2020
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- thyroid nodule
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
product manufactured in and exported from the U.S.
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Thyroid Nodule
-
Tseung Kwan O Hospital, Hong KongNot yet recruitingBenign Thyroid Nodule | Suspicious Malignant Thyroid Nodule
-
Rijnstate HospitalZonMw: The Netherlands Organisation for Health Research and Development; University... and other collaboratorsRecruitingRadiofrequency Ablation | Thyroid Nodule, Toxic or With Hyperthyroidism | Autonomous Thyroid Function | Thyroid Nodule; Hyperthyroidism | Iodine Hyperthyroidism | Iodine Adverse ReactionNetherlands
-
Aarhus University HospitalOdense University Hospital; University of AarhusEnrolling by invitationThyroid Cancer | Thyroid Nodule (Diagnosis)Denmark
-
Pulse Biosciences, Inc.RecruitingThyroid Nodule (Benign)Italy
-
University of Wisconsin, MadisonNational Cancer Institute (NCI); University of MichiganCompletedThyroid Cancer | Thyroid Nodule | Benign Thyroid NoduleUnited States
-
University of Sao Paulo General HospitalRecruiting
-
Assiut UniversityNot yet recruitingThyroid Nodule (Benign)
-
Fundatia Bio-ForumCompletedBenign Thyroid NoduleRomania
-
Wuhan UniversityRecruitingThyroid Carcinoma | Thyroid Nodule (Benign) | Ablation; RetinaChina
Clinical Trials on thyroidectomy
-
Aristotle University Of ThessalonikiAHEPA University HospitalCompleted
-
Second Military Medical UniversityUnknown
-
Kahramanmaras Sutcu Imam UniversityCompletedThyroid Diseases | Thyroid Cancer | Thyroid Nodule | Thyroid Neoplasms Benign
-
University of AlbertaTerminated
-
Centre Hospitalier Universitaire de NīmesTerminatedGraves Disease | Goiter | Thyroid Nodule | ThyroiditisFrance
-
Assiut UniversityUnknown
-
Tel-Aviv Sourasky Medical CenterCompletedPapillary Thyroid Cancer | Well Differentiated Thyroid Carcinoma
-
University of Colorado, DenverCharite University, Berlin, GermanyTerminatedHypothyroidism | Postsurgical HypothyroidismUnited States
-
Jagiellonian UniversityCompleted